Skip to main content

Makena Side Effects

Generic name: hydroxyprogesterone

Medically reviewed by Drugs.com. Last updated on Apr 16, 2024.

Note: This document provides detailed information about Makena Side Effects associated with hydroxyprogesterone. Some dosage forms listed on this page may not apply specifically to the brand name Makena.

Applies to hydroxyprogesterone: intramuscular oil, subcutaneous solution auto-injector.

Other dosage forms:

Serious side effects of Makena

WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:

Other side effects of Makena

All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away:

These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at https://www.fda.gov/medwatch.

For healthcare professionals

Applies to hydroxyprogesterone: compounding powder, intramuscular solution, subcutaneous solution.

General

The most commonly reported adverse reaction is injection site pain.

Local

Injection site cellulitis was reported in 1 subject. In a study that compared IM injection to subcutaneous auto-injector, injection site pain was reported in 10% of subjects receiving drug via the auto-injector compared with 7% receiving an IM injection. In a second study, 34% reported injection site pain with the auto-injector and 8% with IM injection.[Ref]

Endocrine

Certain pregnancy-related fetal and maternal complications or events were numerically increased in patients receiving this drug compared with placebo including miscarriage at less than 20 weeks (5/209 vs 0/107), stillbirth (6/302 vs 2/153), admission for preterm labor (16% vs 13.8%), preeclampsia or gestation hypertension (8.8% vs 4.6%), gestational diabetes (5.6% vs 4.6%), and oligohydramnios (3.6% vs 1.3%).

Genitourinary

Gastrointestinal

Dermatologic

Nervous system

Respiratory

Pulmonary embolus was reported in 1 patient.

Other

References

1. (2011) "Product Information. Makena (hydroxyprogesterone)." Ther-Rx Corporation

Further information

Makena side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.